MX2011007857A - (1-fenil-2-piridin-4-il)etil esteres del acido benzoico como inhibidores de fosfodiesterasa. - Google Patents
(1-fenil-2-piridin-4-il)etil esteres del acido benzoico como inhibidores de fosfodiesterasa.Info
- Publication number
- MX2011007857A MX2011007857A MX2011007857A MX2011007857A MX2011007857A MX 2011007857 A MX2011007857 A MX 2011007857A MX 2011007857 A MX2011007857 A MX 2011007857A MX 2011007857 A MX2011007857 A MX 2011007857A MX 2011007857 A MX2011007857 A MX 2011007857A
- Authority
- MX
- Mexico
- Prior art keywords
- phenyl
- pyridin
- benzoic acid
- ethyl esters
- phosphodiesterase inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se relaciona con inhibidores de la enzima fosfodiesterasa 4 (PDE4). Más particularmente, la invención se relaciona con los derivados de -fenil-2-piridinil alquilo alcoholes, métodos para preparar tales compuestos, composiciones que los comprenden, combinaciones y usos terapéuticos de los mismos (I) en donde n es 0 o 1; R1 y R2 pueden ser iguales o diferentes, y son seleccionados del grupo que consiste de: - alquilo C1-C6 lineal o ramificado, OR3 en donde R3 es un alquilo C1-C6 lineal o ramificado opcionalmente substituido por uno o más grupos cicloalquilo C3-C7 y - HNSO2R4 en donde R4 es alquilo C1-C4 opcionalmente substituido con uno o más átomos de halógeno o con un grupo C1-C4, en donde por lo menos uno de R1 y R2 es HNSO2R4. Las otras variables son como se definió en las reivindicaciones.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09001660A EP2216327A1 (en) | 2009-02-06 | 2009-02-06 | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
| PCT/EP2010/000676 WO2010089107A1 (en) | 2009-02-06 | 2010-02-04 | Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011007857A true MX2011007857A (es) | 2011-08-15 |
Family
ID=40674203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011007857A MX2011007857A (es) | 2009-02-06 | 2010-02-04 | (1-fenil-2-piridin-4-il)etil esteres del acido benzoico como inhibidores de fosfodiesterasa. |
Country Status (34)
| Country | Link |
|---|---|
| US (5) | US8440834B2 (es) |
| EP (2) | EP2216327A1 (es) |
| JP (2) | JP5612610B2 (es) |
| KR (1) | KR101337728B1 (es) |
| CN (1) | CN102317262B (es) |
| AR (1) | AR075243A1 (es) |
| AU (1) | AU2010211274B2 (es) |
| BR (1) | BRPI1005695A8 (es) |
| CA (1) | CA2751494C (es) |
| CL (1) | CL2011001876A1 (es) |
| CO (1) | CO6400217A2 (es) |
| CY (1) | CY1113764T1 (es) |
| EA (1) | EA019113B1 (es) |
| ES (1) | ES2395528T3 (es) |
| GE (1) | GEP20135919B (es) |
| HK (1) | HK1162508A1 (es) |
| HR (1) | HRP20121004T1 (es) |
| IL (1) | IL214446A (es) |
| JO (1) | JO2761B1 (es) |
| MA (1) | MA33105B1 (es) |
| ME (1) | ME02325B (es) |
| MX (1) | MX2011007857A (es) |
| MY (1) | MY152048A (es) |
| NZ (1) | NZ594413A (es) |
| PE (1) | PE20120055A1 (es) |
| PL (1) | PL2393782T3 (es) |
| PT (1) | PT2393782E (es) |
| RS (1) | RS52605B (es) |
| SG (1) | SG173208A1 (es) |
| SI (1) | SI2393782T1 (es) |
| TN (1) | TN2011000346A1 (es) |
| TW (1) | TWI459945B (es) |
| UA (1) | UA102574C2 (es) |
| WO (1) | WO2010089107A1 (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2022783A1 (en) * | 2007-08-08 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors" |
| EP2216327A1 (en) * | 2009-02-06 | 2010-08-11 | CHIESI FARMACEUTICI S.p.A. | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
| ES2628891T3 (es) * | 2010-08-03 | 2017-08-04 | Chiesi Farmaceutici S.P.A. | Formulación farmacéutica que comprende un inhibidor de fosfodiesterasa |
| SG187258A1 (en) * | 2010-08-03 | 2013-03-28 | Chiesi Farma Spa | Dry powder formulation comprising a phosphodiesterase inhibitor |
| EP2718267B1 (en) * | 2011-06-06 | 2016-08-10 | Chiesi Farmaceutici S.p.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| EP2760838B1 (en) | 2011-09-26 | 2017-05-10 | Chiesi Farmaceutici S.p.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| CN103889972A (zh) * | 2011-10-21 | 2014-06-25 | 奇斯药制品公司 | 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物 |
| WO2013087749A1 (en) * | 2011-12-16 | 2013-06-20 | Chiesi Farmaceutici S.P.A. | Potentiation induced by pde4 inhibitors in the treatment of leukemia |
| IN2014DN10239A (es) * | 2012-06-04 | 2015-08-07 | Chiesi Farma Spa | |
| CN110698459B (zh) * | 2012-12-05 | 2023-05-05 | 奇斯药制品公司 | 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇衍生物 |
| AR093795A1 (es) * | 2012-12-05 | 2015-06-24 | Chiesi Farm Spa | Oxidos de piridinio, composiciones farmaceuticas que los comprenden y su uso en el tratamiento de enfermedades respiratorias |
| RU2015121037A (ru) * | 2012-12-05 | 2017-01-11 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные фенилэтилпиридина в качестве ингибиторов pde-4 |
| WO2014086849A1 (en) * | 2012-12-05 | 2014-06-12 | Chiesi Farmaceutici S.P.A. | Phenylethylpyridine derivatives as pde4-inhibitors |
| US9427376B2 (en) | 2013-10-10 | 2016-08-30 | Chiesi Farmaceutici S.P.A. | Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient |
| HUE053112T2 (hu) * | 2013-10-22 | 2021-06-28 | Chiesi Farm Spa | PDE 4 inhibitor kristályos formája |
| CA2932486A1 (en) | 2013-12-05 | 2015-06-11 | Chiesi Farmaceutici S.P.A. | Benzhydryl derivatives for the treatment of respiratory diseases |
| ES2655047T3 (es) | 2013-12-05 | 2018-02-16 | Chiesi Farmaceutici S.P.A. | Derivados de heteroarilo para el tratamiento de enfermedades respiratorias |
| US9890151B2 (en) | 2014-06-04 | 2018-02-13 | Chiesi Farmaceutici S.P.A. | 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)- 2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors |
| EP3152202B1 (en) | 2014-06-04 | 2018-11-28 | Chiesi Farmaceutici S.p.A. | 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as pde-4 inhibitors and muscarinic m3 receptor antagonists |
| US9326976B2 (en) | 2014-06-05 | 2016-05-03 | Chiesi Farmaceutici S.P.A. | Carbamate derivatives |
| US9763924B2 (en) | 2014-06-05 | 2017-09-19 | Chiesi Farmaceutici S.P.A. | Aminoester derivatives |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
| WO2018017713A1 (en) * | 2016-07-20 | 2018-01-25 | Allergan, Inc. | Methods, compositions, and compounds for treatment of dermatological and ocular conditions |
| MA51413A (fr) * | 2017-12-28 | 2021-04-28 | Chiesi Farm Spa | Utilisation de dérivés d'alcool alkylique de 1-phényl-2-pyridinyl pour le traitement de la fibrose kystique |
| KR20210040102A (ko) | 2018-07-27 | 2021-04-12 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입용 건조 분말 제제를 위한 신규 담체 입자 |
| CN115466169B (zh) * | 2021-06-10 | 2024-03-26 | 中国医学科学院药物研究所 | 取代邻苯二酚醚类化合物及其制备方法和应用 |
| WO2023117985A1 (en) | 2021-12-21 | 2023-06-29 | Chiesi Farmaceutici S.P.A. | Dry powder formulations filled in an inhaler with improved resistance to humidity |
| WO2023208982A1 (en) | 2022-04-27 | 2023-11-02 | Chiesi Farmaceutici S.P.A. | Crystal form of a pde4 inhibitor |
| WO2024027901A1 (en) | 2022-08-02 | 2024-02-08 | Chiesi Farmaceutici S.P.A. | Predictive biomarker of clinical response to a pde4 inhibitor |
| WO2024062005A1 (en) | 2022-09-22 | 2024-03-28 | Chiesi Farmaceutici S.P.A. | Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor |
| WO2024062006A1 (en) | 2022-09-22 | 2024-03-28 | Chiesi Farmaceutici S.P.A. | Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor |
| WO2024062007A1 (en) | 2022-09-22 | 2024-03-28 | Chiesi Farmaceutici S.P.A. | Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW263495B (es) * | 1992-12-23 | 1995-11-21 | Celltech Ltd | |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| SI0706513T1 (en) * | 1993-07-02 | 2002-10-31 | Altana Pharma Ag | Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| WO2008006509A1 (en) * | 2006-07-14 | 2008-01-17 | Chiesi Farmaceutici S.P.A. | Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors |
| EP2022783A1 (en) * | 2007-08-08 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors" |
| EP2070913A1 (en) * | 2007-12-14 | 2009-06-17 | CHIESI FARMACEUTICI S.p.A. | Ester derivatives as phosphodiesterase inhibitors |
| EP2110375A1 (en) * | 2008-04-14 | 2009-10-21 | CHIESI FARMACEUTICI S.p.A. | Phosphodiesterase-4 inhibitors belonging to the tertiary amine class |
| EP2216327A1 (en) * | 2009-02-06 | 2010-08-11 | CHIESI FARMACEUTICI S.p.A. | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
| SG187258A1 (en) * | 2010-08-03 | 2013-03-28 | Chiesi Farma Spa | Dry powder formulation comprising a phosphodiesterase inhibitor |
| ES2628891T3 (es) * | 2010-08-03 | 2017-08-04 | Chiesi Farmaceutici S.P.A. | Formulación farmacéutica que comprende un inhibidor de fosfodiesterasa |
| EP2718267B1 (en) | 2011-06-06 | 2016-08-10 | Chiesi Farmaceutici S.p.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| EP2760838B1 (en) | 2011-09-26 | 2017-05-10 | Chiesi Farmaceutici S.p.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| CN103889972A (zh) | 2011-10-21 | 2014-06-25 | 奇斯药制品公司 | 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物 |
| IN2014DN10239A (es) | 2012-06-04 | 2015-08-07 | Chiesi Farma Spa | |
| CN110698459B (zh) | 2012-12-05 | 2023-05-05 | 奇斯药制品公司 | 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇衍生物 |
-
2009
- 2009-02-06 EP EP09001660A patent/EP2216327A1/en not_active Withdrawn
-
2010
- 2010-02-03 JO JO201033A patent/JO2761B1/en active
- 2010-02-04 EA EA201190099A patent/EA019113B1/ru unknown
- 2010-02-04 ME MEP-2016-19A patent/ME02325B/me unknown
- 2010-02-04 MX MX2011007857A patent/MX2011007857A/es active IP Right Grant
- 2010-02-04 UA UAA201108827A patent/UA102574C2/ru unknown
- 2010-02-04 AR ARP100100311A patent/AR075243A1/es not_active Application Discontinuation
- 2010-02-04 KR KR1020117016842A patent/KR101337728B1/ko active IP Right Grant
- 2010-02-04 JP JP2011548600A patent/JP5612610B2/ja active Active
- 2010-02-04 CA CA2751494A patent/CA2751494C/en active Active
- 2010-02-04 PL PL10704746T patent/PL2393782T3/pl unknown
- 2010-02-04 MA MA34150A patent/MA33105B1/fr unknown
- 2010-02-04 WO PCT/EP2010/000676 patent/WO2010089107A1/en active Application Filing
- 2010-02-04 BR BRPI1005695A patent/BRPI1005695A8/pt not_active Application Discontinuation
- 2010-02-04 GE GEAP201012324A patent/GEP20135919B/en unknown
- 2010-02-04 SI SI201030094T patent/SI2393782T1/sl unknown
- 2010-02-04 EP EP10704746A patent/EP2393782B1/en active Active
- 2010-02-04 RS RS20120547A patent/RS52605B/en unknown
- 2010-02-04 CN CN201080006643.7A patent/CN102317262B/zh active Active
- 2010-02-04 TW TW099103291A patent/TWI459945B/zh active
- 2010-02-04 AU AU2010211274A patent/AU2010211274B2/en active Active
- 2010-02-04 PE PE2011001441A patent/PE20120055A1/es active IP Right Grant
- 2010-02-04 NZ NZ594413A patent/NZ594413A/xx unknown
- 2010-02-04 PT PT107047466T patent/PT2393782E/pt unknown
- 2010-02-04 ES ES10704746T patent/ES2395528T3/es active Active
- 2010-02-04 MY MYPI2011003639 patent/MY152048A/en unknown
- 2010-02-04 SG SG2011056165A patent/SG173208A1/en unknown
- 2010-02-05 US US12/700,926 patent/US8440834B2/en active Active
-
2011
- 2011-07-13 TN TN2011000346A patent/TN2011000346A1/fr unknown
- 2011-08-04 CL CL2011001876A patent/CL2011001876A1/es unknown
- 2011-08-04 IL IL214446A patent/IL214446A/en active IP Right Grant
- 2011-08-04 CO CO11098671A patent/CO6400217A2/es not_active Application Discontinuation
-
2012
- 2012-03-28 HK HK12103106.1A patent/HK1162508A1/xx unknown
- 2012-09-14 US US13/618,346 patent/US20130012487A1/en not_active Abandoned
- 2012-12-04 CY CY20121101183T patent/CY1113764T1/el unknown
- 2012-12-06 HR HRP20121004AT patent/HRP20121004T1/hr unknown
-
2013
- 2013-06-28 US US13/930,304 patent/US8648204B2/en active Active
- 2013-12-17 US US14/108,731 patent/US8859778B2/en active Active
-
2014
- 2014-09-04 JP JP2014179895A patent/JP2015038079A/ja active Pending
- 2014-09-10 US US14/482,287 patent/US9056176B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2011000346A1 (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors | |
| PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
| CA2757418C (en) | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same | |
| SG195319A1 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
| JO3181B1 (ar) | مشتقات كمحول ثاني الكيل البايردينيل - أحادي الفينيل كأنزيم ثنائي استرات الفوسفود | |
| WO2008030744A3 (en) | Inhibitors of c-met and uses thereof | |
| MX340360B (es) | Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas. | |
| MY140841A (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
| MX2010010135A (es) | Derivados de hidroximoil-tetrazol fungicidas. | |
| MD4556C1 (ro) | Compuşi inhibitori ai activităţii catehol O-metiltransferazei | |
| NZ596228A (en) | Compositions and methods for the treatment of inflammation | |
| UY32630A (es) | Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica. | |
| UA97821C2 (en) | Cyclized derivatives as eg-5 inhibitors | |
| WO2013057013A3 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
| NZ592429A (en) | PHENANTHROINDOLIZIDINE DERIVATIVE AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT | |
| MX2010006787A (es) | Análogos halogenados de agentes anti-fibroticos. | |
| MX339361B (es) | Derivados de alternano. | |
| IN2014DN06122A (es) | ||
| WO2009140101A3 (en) | Imidazopyridine compounds useful as mmp-13 inhibitors | |
| BR112014013906A2 (pt) | ésteres de fosfato aromáticos como componentes de formulação agroquímica | |
| MX339727B (es) | Composicion farmaceutica que comprende un compuesto de 11-desoxi-prostaglandina y metodo para estabilizar el compuesto. | |
| AU2016219657A1 (en) | Stable pharmaceutical composition and methods of using same | |
| TN2010000362A1 (en) | Oxim derivatives as hsp90 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |